What participants understand about a maternal serum alpha-fetoprotein screening program

Area of Science:

• Prenatal screening
• Maternal health
• Fetal development

Background:

• Maternal serum alphafetoprotein (MSAFP) screening is a common method for detecting fetal neural tube defects (NTDs).
• Understanding pregnant women's knowledge of such screening programs is crucial for effective implementation and patient counseling.

Purpose of the Study:

• To assess the knowledge of pregnant women enrolled in an MSAFP screening program regarding neural tube defects.
• To compare the knowledge levels between women in the screening program and a control group.

Main Methods:

• Knowledge assessment using two distinct tests.
• Comparison of scores between pregnant women in the MSAFP screening program and a control group not offered screening.

Main Results:

• Women participating in the MSAFP screening program demonstrated higher scores on both knowledge tests compared to the control group.
• Despite higher scores, substantial knowledge deficits were identified in women within the screening program.
• A tendency for women to interpret negative MSAFP results too positively, viewing them as a guarantee of overall fetal health, was observed.

Conclusions:

• While MSAFP screening programs may improve some aspects of maternal knowledge, they do not fully address knowledge gaps related to NTDs.
• There is a need for enhanced patient education to ensure accurate understanding of screening test results and their implications.
• Over-interpretation of negative results as complete assurance of fetal health requires further attention in counseling strategies.